MX2023002037A - Proceso e intermediarios para preparar un inhibidor de las cinasas de janus (jak). - Google Patents
Proceso e intermediarios para preparar un inhibidor de las cinasas de janus (jak).Info
- Publication number
- MX2023002037A MX2023002037A MX2023002037A MX2023002037A MX2023002037A MX 2023002037 A MX2023002037 A MX 2023002037A MX 2023002037 A MX2023002037 A MX 2023002037A MX 2023002037 A MX2023002037 A MX 2023002037A MX 2023002037 A MX2023002037 A MX 2023002037A
- Authority
- MX
- Mexico
- Prior art keywords
- preparing
- intermediates
- jak inhibitor
- jak
- inhibitor
- Prior art date
Links
- 239000000543 intermediate Substances 0.000 title abstract 2
- 229940122245 Janus kinase inhibitor Drugs 0.000 title 1
- 239000002144 L01XE18 - Ruxolitinib Substances 0.000 abstract 1
- HFNKQEVNSGCOJV-OAHLLOKOSA-N ruxolitinib Chemical compound C1([C@@H](CC#N)N2N=CC(=C2)C=2C=3C=CNC=3N=CN=2)CCCC1 HFNKQEVNSGCOJV-OAHLLOKOSA-N 0.000 abstract 1
- 229960000215 ruxolitinib Drugs 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C255/00—Carboxylic acid nitriles
- C07C255/01—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms
- C07C255/31—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms having cyano groups bound to acyclic carbon atoms of a carbon skeleton containing rings other than six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
- C07C59/235—Saturated compounds containing more than one carboxyl group
- C07C59/245—Saturated compounds containing more than one carboxyl group containing hydroxy or O-metal groups
- C07C59/255—Tartaric acid
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Enzymes And Modification Thereof (AREA)
Abstract
La presente invención se relaciona con procesos para preparar ruxolitinib, o una sal de este, e intermediarios relacionados sintéticos asociados a estos.
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US202063067097P | 2020-08-18 | 2020-08-18 | |
US202163214012P | 2021-06-23 | 2021-06-23 | |
US202163217498P | 2021-07-01 | 2021-07-01 | |
PCT/US2021/046298 WO2022040180A1 (en) | 2020-08-18 | 2021-08-17 | Process and intermediates for preparing a jak inhibitor |
Publications (1)
Publication Number | Publication Date |
---|---|
MX2023002037A true MX2023002037A (es) | 2023-06-12 |
Family
ID=77655708
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2023002037A MX2023002037A (es) | 2020-08-18 | 2021-08-17 | Proceso e intermediarios para preparar un inhibidor de las cinasas de janus (jak). |
Country Status (16)
Country | Link |
---|---|
US (2) | US11905292B2 (es) |
EP (1) | EP4200300A1 (es) |
JP (1) | JP2023539126A (es) |
KR (1) | KR20230096973A (es) |
AU (1) | AU2021329303A1 (es) |
CA (1) | CA3192099A1 (es) |
CL (1) | CL2023000480A1 (es) |
CO (1) | CO2023003281A2 (es) |
CR (1) | CR20230129A (es) |
DO (1) | DOP2023000035A (es) |
EC (1) | ECSP23019417A (es) |
IL (1) | IL300555A (es) |
MX (1) | MX2023002037A (es) |
PE (1) | PE20231743A1 (es) |
TW (1) | TW202227448A (es) |
WO (1) | WO2022040180A1 (es) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
MX2023002035A (es) | 2020-08-18 | 2023-06-12 | Incyte Corp | Proceso e intermediarios para preparar un inhibidor de cinasa janus 1 (jak1). |
CN115850115B (zh) * | 2022-11-25 | 2023-08-01 | 上海药坦药物研究开发有限公司 | 鲁索利替尼中间体及其制备方法 |
Family Cites Families (64)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB812366A (en) | 1955-08-18 | 1959-04-22 | Wellcome Found | Improvements in and relating to derivatives of pyrimidine and the preparation thereof |
US5102904A (en) | 1989-12-08 | 1992-04-07 | American Cyanamid Company | N-oxygenated arylpyrrole insecticidal, acaricidal and nematicidal agents and use thereas |
EP1551410A2 (en) | 2002-09-06 | 2005-07-13 | Smithkline Beecham Corporation | Novel compounds |
CA2566160C (en) | 2004-05-27 | 2011-01-18 | Pfizer Products Inc. | Pyrrolopyrimidine derivatives useful in cancer treatment |
AR054416A1 (es) | 2004-12-22 | 2007-06-27 | Incyte Corp | Pirrolo [2,3-b]piridin-4-il-aminas y pirrolo [2,3-b]pirimidin-4-il-aminas como inhibidores de las quinasas janus. composiciones farmaceuticas. |
KR100987870B1 (ko) | 2005-07-29 | 2010-10-13 | 화이자 프로덕츠 인코포레이티드 | 피롤로[2,3-d]피리미딘 유도체, 이들의 중간체 및 합성 |
HUE030235T2 (en) | 2005-12-13 | 2017-04-28 | Incyte Holdings Corp | Heteroaryl-substituted pyrrolo [2,3-b] pyridines and pyrrolo [2,3-b] pyrimidines as Janus kinase inhibitors |
CN2928286Y (zh) | 2006-01-06 | 2007-08-01 | 水城钢铁(集团)有限责任公司 | 预入口导卫装置 |
EA031335B1 (ru) | 2006-02-02 | 2018-12-28 | Миллениум Фармасьютикалз, Инк. | Производные пирролопиримидинов |
CL2008001709A1 (es) | 2007-06-13 | 2008-11-03 | Incyte Corp | Compuestos derivados de pirrolo [2,3-b]pirimidina, moduladores de quinasas jak; composicion farmaceutica; y uso en el tratamiento de enfermedades tales como cancer, psoriasis, artritis reumatoide, entre otras. |
EP3070090B1 (en) | 2007-06-13 | 2018-12-12 | Incyte Holdings Corporation | Use of salts of the janus kinase inhibitor (r)-3-(4-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-1h- pyrazol-1-yl)-3- cyclopentylpropanenitrile |
AU2008281543A1 (en) | 2007-08-01 | 2009-02-05 | Pfizer Inc. | Pyrazole compounds and their use as Raf inhibitors |
NZ585139A (en) | 2007-11-16 | 2012-05-25 | Incyte Corp | 4-pyrazolyl-n-arylpyrimidin-2-amines and 4-pyrazolyl-n-heteroarylpyrimidin-2-amines as jak inhibitors |
ES2602577T3 (es) | 2008-03-11 | 2017-02-21 | Incyte Holdings Corporation | Derivados de azetidina y ciclobutano como inhibidores de JAK |
CL2009001884A1 (es) | 2008-10-02 | 2010-05-14 | Incyte Holdings Corp | Uso de 3-ciclopentil-3-[4-(7h-pirrolo[2,3-d]pirimidin-4-il)-1h-pirazol-1-il)propanonitrilo, inhibidor de janus quinasa, y uso de una composición que lo comprende para el tratamiento del ojo seco. |
JOP20190231A1 (ar) | 2009-01-15 | 2017-06-16 | Incyte Corp | طرق لاصلاح مثبطات انزيم jak و المركبات الوسيطة المتعلقة به |
WO2010116282A1 (en) | 2009-04-10 | 2010-10-14 | Pfizer Inc. | 4, 5-dihydro-lh-pyrazole compounds and their pharmaceutical uses |
EA020494B1 (ru) | 2009-05-22 | 2014-11-28 | Инсайт Корпорейшн | 3-[4-(7H-ПИРРОЛО[2,3-d]ПИРИМИДИН-4-ИЛ)-1H-ПИРАЗОЛ-1-ИЛ]ОКТАН- ИЛИ ГЕПТАННИТРИЛ КАК JAK-ИНГИБИТОРЫ |
AR076794A1 (es) | 2009-05-22 | 2011-07-06 | Incyte Corp | Derivados de n-(hetero)aril-pirrolidina de pirazol-4-il-pirrolo [2,3-d]pirimidinas y pirrol-3-il-pirrolo [2,3-d ]pirimidinas como inhibidores de la quinasa janus y composiciones farmaceuticas que los contienen |
AR078012A1 (es) | 2009-09-01 | 2011-10-05 | Incyte Corp | Derivados heterociclicos de las pirazol-4-il- pirrolo (2,3-d) pirimidinas como inhibidores de la quinasa janus |
WO2011044481A1 (en) | 2009-10-09 | 2011-04-14 | Incyte Corporation | Hydroxyl, keto, and glucuronide derivatives of 3-(4-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-1h-pyrazol-1-yl)-3-cyclopentylpropanenitrile |
NZ629615A (en) | 2009-11-06 | 2016-01-29 | Plexxikon Inc | Compounds and methods for kinase modulation, and indications therefor |
CN105906631A (zh) | 2009-11-18 | 2016-08-31 | 普莱希科公司 | 用于激酶调节的化合物和方法及其适应症 |
BR112012020693B1 (pt) | 2010-02-18 | 2020-05-12 | Incyte Holdings Corporation | Derivados de ciclobutano e metilciclobutano como inibidores de janus quinase e composição que os compreende |
MX347851B (es) | 2010-03-10 | 2017-05-16 | Incyte Corp | Derivados de piperidin-4-il azetidina como inhibidores de janus cinasa 1 (jak1). |
TWI619713B (zh) | 2010-04-21 | 2018-04-01 | 普雷辛肯公司 | 用於激酶調節的化合物和方法及其適應症 |
EP3087972A1 (en) | 2010-05-21 | 2016-11-02 | Incyte Holdings Corporation | Topical formulation for a jak inhibitor |
SG190839A1 (en) | 2010-11-19 | 2013-07-31 | Incyte Corp | Cyclobutyl substituted pyrrolopyridine and pyrrolopyrimidine derivatives as jak inhibitors |
EP2640725B1 (en) | 2010-11-19 | 2015-01-07 | Incyte Corporation | Heterocyclic-substituted pyrrolopyridines and pyrrolopyrimidines as jak inhibitors |
AR086983A1 (es) | 2011-06-20 | 2014-02-05 | Incyte Corp | Derivados de azetidinil fenil, piridil o pirazinil carboxamida como inhibidores de jak |
MX365311B (es) | 2011-08-12 | 2019-05-29 | Nissan Chemical Ind Ltd | Compuestos heterocíclicos tricíclicos inhibidores de jak. |
TW201313721A (zh) | 2011-08-18 | 2013-04-01 | Incyte Corp | 作為jak抑制劑之環己基氮雜環丁烷衍生物 |
UA111854C2 (uk) | 2011-09-07 | 2016-06-24 | Інсайт Холдінгс Корпорейшн | Способи і проміжні сполуки для отримання інгібіторів jak |
AR091079A1 (es) | 2012-05-18 | 2014-12-30 | Incyte Corp | Derivados de pirrolopirimidina y pirrolopiridina sustituida con piperidinilciclobutilo como inhibidores de jak |
KR20220162825A (ko) | 2012-11-15 | 2022-12-08 | 인사이트 홀딩스 코포레이션 | 룩솔리티니브의 서방성 제형 |
AU2014225938B2 (en) | 2013-03-06 | 2018-07-19 | Incyte Holdings Corporation | Processes and intermediates for making a JAK inhibitor |
DK3786162T3 (da) | 2013-05-17 | 2023-10-09 | Incyte Holdings Corp | Bipyrazolderivater som jak-inhibitorer |
KR20160045081A (ko) | 2013-08-07 | 2016-04-26 | 인사이트 코포레이션 | Jak1 억제제용 지속 방출 복용 형태 |
TW201625643A (zh) | 2014-04-30 | 2016-07-16 | 英塞特公司 | 製備jak1抑制劑之方法及其新形式 |
EP3183252B1 (en) | 2014-08-21 | 2021-05-12 | ratiopharm GmbH | Oxalate salt of ruxolitinib |
EP3183253B1 (en) | 2014-08-21 | 2018-06-27 | ratiopharm GmbH | Salt of (r)-3-(4-(7h-pyrrolo [2,3-d]pyrimidin-4-yl)-lh-pyrazol-l-yl)-3-cyclopentylpropanenitrile with benzenesulfonic acid |
WO2016035014A1 (en) | 2014-09-01 | 2016-03-10 | Sun Pharmaceutical Industries Limited | Processes for the preparation of ruxolitinib phosphate |
WO2016063294A2 (en) | 2014-10-20 | 2016-04-28 | Msn Laboratories Private Limited | Process for the preparation of (r)-3-(4-(7h-pyrrolo[2,3-d], pyrimidin-4-yl)-1 h-pyrazol-1-yl)-3-cyclopentylpropanenitrile phosphate and its polymorphs thereof |
CU20170105A7 (es) | 2015-02-24 | 2017-10-05 | Pfizer | Derivados de nucleosidos sustituidos útiles como agentes antineoplásicos |
CN106397443A (zh) | 2015-07-17 | 2017-02-15 | 浙江九洲药业股份有限公司 | 一种吡咯嘧啶类衍生物中间体的制备方法 |
CZ2015575A3 (cs) | 2015-08-26 | 2017-03-08 | Zentiva, K.S. | Soli 5-fluoro-3-fenyl-2-[(1S)-1-(9H-purin-6-ylamino)propyl]quinazolin-4-onu a jejich příprava |
CA3008909C (en) | 2015-12-23 | 2023-10-03 | The University Of British Columbia | Lipid-linked prodrugs |
CN108699063B (zh) | 2015-12-31 | 2020-06-26 | 正大天晴药业集团股份有限公司 | 一种芦可替尼的合成工艺 |
CZ201629A3 (cs) | 2016-01-22 | 2017-08-02 | Zentiva, K.S. | Krystalické modifikace solí (3R)-3-cyklopentyl-3-[4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)pyrazol-1-yl]propannitrilu a způsoby jejich přípravy |
CN107513069A (zh) | 2016-06-16 | 2017-12-26 | 正大天晴药业集团股份有限公司 | 手性吡咯并嘧啶化合物的制备方法 |
IN201641026603A (es) | 2016-08-04 | 2018-02-09 | ||
CN107722012B (zh) | 2016-08-11 | 2020-05-29 | 斯福瑞(南通)制药有限公司 | 制备4-氯-7H-吡咯并[2,3-d]嘧啶的方法 |
CN107759601B (zh) | 2016-08-23 | 2020-09-11 | 苏州旺山旺水生物医药有限公司 | 一种jak抑制剂及其盐的制备方法 |
CN107759623B (zh) | 2016-08-23 | 2020-08-14 | 苏州旺山旺水生物医药有限公司 | Jak抑制剂的中间体及其制备方法 |
JP2019532944A (ja) | 2016-09-23 | 2019-11-14 | セルイプセ | Limk介在性疾患における、limキナーゼ阻害剤、医薬組成物および使用方法 |
CN109651424B (zh) | 2017-10-11 | 2021-01-22 | 新发药业有限公司 | 一种7-保护基-4-(1-氢-吡唑-4-基)吡咯[2,3-d]嘧啶的合成方法 |
US10766900B2 (en) | 2017-12-29 | 2020-09-08 | Formosa Laboratories, Inc. | Baricitinib intermediate, method for forming Baricitinib intermediate, and method for preparing Baricitinib or pharmaceutically acceptable salt thereof |
TWI797242B (zh) | 2018-01-30 | 2023-04-01 | 美商英塞特公司 | 製備jak抑制劑之方法及中間物 |
KR20210011922A (ko) | 2018-05-21 | 2021-02-02 | 피아이 인더스트리스 엘티디. | 치환된 헤테로사이클릭 화합물의 제조 방법 |
JP2022520047A (ja) | 2019-02-06 | 2022-03-28 | コンサート ファーマシューティカルズ インコーポレイテッド | 鏡像異性的に濃縮されたjak阻害剤を調製するための方法 |
CN110724145A (zh) | 2019-11-01 | 2020-01-24 | 廖文杰 | 一种医药中间体4-氯吡咯并嘧啶的合成方法 |
MX2023002035A (es) | 2020-08-18 | 2023-06-12 | Incyte Corp | Proceso e intermediarios para preparar un inhibidor de cinasa janus 1 (jak1). |
WO2023288197A1 (en) | 2021-07-12 | 2023-01-19 | Incyte Corporation | Process and intermediates for preparing baricitinib |
CN113480546A (zh) | 2021-07-30 | 2021-10-08 | 江苏君若药业有限公司 | 巴瑞克替尼及其衍生物的制备 |
-
2021
- 2021-08-17 KR KR1020237009291A patent/KR20230096973A/ko unknown
- 2021-08-17 WO PCT/US2021/046298 patent/WO2022040180A1/en active Application Filing
- 2021-08-17 CA CA3192099A patent/CA3192099A1/en active Pending
- 2021-08-17 IL IL300555A patent/IL300555A/en unknown
- 2021-08-17 US US17/404,613 patent/US11905292B2/en active Active
- 2021-08-17 EP EP21766351.7A patent/EP4200300A1/en active Pending
- 2021-08-17 CR CR20230129A patent/CR20230129A/es unknown
- 2021-08-17 MX MX2023002037A patent/MX2023002037A/es unknown
- 2021-08-17 PE PE2023000317A patent/PE20231743A1/es unknown
- 2021-08-17 JP JP2023512140A patent/JP2023539126A/ja active Pending
- 2021-08-17 AU AU2021329303A patent/AU2021329303A1/en active Pending
- 2021-08-18 TW TW110130538A patent/TW202227448A/zh unknown
-
2023
- 2023-02-16 CL CL2023000480A patent/CL2023000480A1/es unknown
- 2023-02-17 DO DO2023000035A patent/DOP2023000035A/es unknown
- 2023-03-16 EC ECSENADI202319417A patent/ECSP23019417A/es unknown
- 2023-03-16 CO CONC2023/0003281A patent/CO2023003281A2/es unknown
- 2023-12-15 US US18/541,579 patent/US20240166655A1/en active Pending
Also Published As
Publication number | Publication date |
---|---|
KR20230096973A (ko) | 2023-06-30 |
AU2021329303A1 (en) | 2023-04-06 |
CL2023000480A1 (es) | 2023-08-04 |
WO2022040180A1 (en) | 2022-02-24 |
EP4200300A1 (en) | 2023-06-28 |
TW202227448A (zh) | 2022-07-16 |
CR20230129A (es) | 2023-07-13 |
IL300555A (en) | 2023-04-01 |
ECSP23019417A (es) | 2023-04-28 |
CA3192099A1 (en) | 2022-02-24 |
PE20231743A1 (es) | 2023-10-31 |
DOP2023000035A (es) | 2023-06-15 |
JP2023539126A (ja) | 2023-09-13 |
CO2023003281A2 (es) | 2023-06-30 |
US11905292B2 (en) | 2024-02-20 |
US20220056035A1 (en) | 2022-02-24 |
US20240166655A1 (en) | 2024-05-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX2023002035A (es) | Proceso e intermediarios para preparar un inhibidor de cinasa janus 1 (jak1). | |
PH12019502264A1 (en) | Fused imidazo-piperidine jak inhibitors compound | |
MX2023002037A (es) | Proceso e intermediarios para preparar un inhibidor de las cinasas de janus (jak). | |
PH12019502286A1 (en) | Process for preparing an optically active pyrimidinium compounds | |
PH12021550388A1 (en) | Process for preparing jak inhibitors and intermediates thereof | |
MY186296A (en) | Novel promoter and use thereof | |
MX2021015546A (es) | Proceso para preparar 4-amino-piridazinas. | |
PH12019502386A1 (en) | Process for preparing s-containing pyrimidinium compounds | |
MX2021008965A (es) | Proceso para preparar un agonista dual de gip/glp1. | |
EP4265597A3 (en) | Synthesis of omecamtiv mecarbil | |
ZA202306226B (en) | Sulfone derivative production method | |
EA202090933A1 (ru) | Способ получения гербицидных соединений пиридазинона | |
MX2019001228A (es) | Metodo de produccion del compuesto de pirazol-amida. | |
MX2022002017A (es) | Metodo para producir derivado de heterociclideno acetamida. | |
IL279168B (en) | A process for the preparation of eribulin | |
MX2019009242A (es) | Un proceso novedoso para la sintesis de 1-aril-1-trifluoro-metil-c iclopropanos. | |
MX2021007511A (es) | Procedimiento para la preparacion de anilinas sustituidas. | |
MX2023004950A (es) | Proceso para purificacion de pleuromutilinas. | |
MX2023000970A (es) | Metodo de preparacion de aminofuranos. | |
CL2021000663A1 (es) | Proceso para la producción de gas de síntesis. | |
MX2020010343A (es) | Proceso para la purificacion de biocomposiciones complejas. | |
MX2022006044A (es) | Proceso para preparar analogos de araquidonoiletanolamina. | |
MX2022006856A (es) | Proceso e intermediarios para la produccion de formula (i). | |
AU2019248350A8 (en) | Process for making sarecycline hydrochloride | |
ZA202301455B (en) | Process for preparation of mesotrione and its intermediates |